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Universitätsmedizin Berlin, Berlin, GermanyAbstractSurveillance systems for hospital infections are reporting increasing
rates of extended-spectrum β-lactamase (ESBL)-positive
Enterobacteriaceae in Europe. We aimed to perform a national
survey on this trend and on the regional distribution of
nosocomial infections due to ESBL-positive Enterobacteriaceae in
German hospitals. Data from 2007 to 2012 from two components
of the German national nosocomial infection surveillance system
were used for this analysis. The data derive from intensive care
units and surgical departments. Independent factors determining
the proportion of ESBL-positive Enterobacteriaceae among
nosocomial infections due to Enterobacteriaceae and changes in its
regional distribution (broken down into German federal states)
were calculated by regression analysis. From 2007 to 2012, the
data showed a signiﬁcantly increasing proportion of ESBL-positive
Enterobacteriaceae in surgical site infections (from 11.46 to 15.38,
134%, p 0.003), urinary tract infections (9.36 to 16.56, 177%, p
<0.001) and lower respiratory tract infections (11.91 to 14.70,
123%, p <0.001) due to Enterobacteriaceae. Factors independently
associated with a growing proportion were: Thuringia (p 0.009;
odds ratio (OR) 1.53), North Rhine-Westphalia (p <0.001; OR
1.41) and general surgery ward (p 0.002; OR 1.47). The
proportion of ESBL-positive Enterobacteriaceae in nosocomial
infections has signiﬁcantly increased in Germany over the last 6
years. Hospitals in Central Germany and surgical departments in
all of Germany are especially affected by this development.
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E-mail: rasmus.leistner@charite.deIntroductionThird-generation cephalosporin resistance in Enter-
obacteriaceae is an important issue in hospital infections and
intensive care [1,2]. In order to obtain a clinical view of the
proportion of infections due to ESBL-positive Enter-
obacteriaceae (ESBL-E), we aimed to perform an over-time
analysis on the proportion of ESBL resistance based on re-
ported nosocomial infections associated with Enter-
obacteriaceae within the German national nosocomial infection
surveillance system (KISS). KISS was established in 1997
following the example of the U.S. National Nosocomial In-
fections Surveillance (NNIS) system, initially focusing on
intensive care unit (ITS-KISS) and postsurgery patients (OP-
KISS). As in the NNIS system, KISS was set up with voluntary
participation and conﬁdential data feedback to participating
units. Our analysis concentrates on data on nosocomial surgical
site infections (OP-KISS) and nosocomial infections in intensive
care units (ITS-KISS).MethodsData from two components of the German national nosocomial
surveillance system (KISS) from the period from 2007 to 2012
were used for the analysis: data on nosocomial primary
bloodstream infections and urinary tract infections from
intensive care units (ICU) and OP-KISS data on surgical site
infections (SSI) following a wide range of procedures from
surgical departments. Nosocomial infections were determinedClin Microbiol Infect 2015; 21: 255.e1–255.e5
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trol and Prevention. Active prospective surveillance of SSI—
including lower respiratory tract infection, urinary tract infec-
tion and bloodstream infection— is performed by trained staff.
Detailed methods for OP-KISS [3] and ITS-KISS [4–6] have
been previously described.
The proportion of ESBL-positive organisms among nosoco-
mial infections due to Enterobacteriaceae was calculated by
dividing the number of all nosocomial infections due to ESBL-
producing Enterobacteriaceae by the number of all infections
due to Enterobacteriaceae, multiplied by 100. A Cochrane-
Armitage test was used as univariate trend analysis of the
ESBL proportion among nosocomial infections due to Enter-
obacteriaceae between 2007 and 2012.
To assess the inﬂuence of different factors on the trend of
the ESBL proportion among nosocomial Enterobacteriaceae
infections, a multivariate logistic regression analysis was per-
formed. The following variables were considered in the model
by forward selection: year (2007 to 2012), sex, age (0–50,
51–65, 66–70, 71–120 years), type of hospital (university
hospital, academic teaching hospital, other hospital), season,
type of ICU or type of surgical department, and hospital size
(400 beds, >400 beds). Parameters were entered into the
model at a signiﬁcance level of p <0.05 and were removed at p
>0.06.
To analyse differences in the geographical distribution of the
proportion of ESBL, we analysed the hospitals’ geographical
location by federal state. The data set consisted of sets from
2011 and 2012. Further model parameters were the same as
for the yearly trend analysis. To assess their individual inﬂuence
separately, each parameter was binary coded (with refer-
ence = 0). Only the parameter of survey year was analysed as
continuous parameter. Stepwise forward selection was used to
derive a logistic regression model. Parameters were enteredFIG. 1. Proportion of ESBL over time of nosocomial infections due to Enter
ESBL, extended-spectrum β-lactamase; SSI, surgical site infection; LRTI, lower
infection.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectinto the model at a signiﬁcance level of p 0.05 and were
removed at p >0.05.
All computations were performed by R 3.01 (R Foundation
for Statistical Computing Vienna, Austria; mapping material:
http://gadm.org) and SAS 9.3 (SAS Institute, Cary, NC).ResultsOf the existing 2017 hospitals in Germany in 2012, 645 ICUs
with 9011 intensive care beds sent data to ITS-KISS and 681
surgical departments reported data to OP-KISS. From 2007 to
2012, we found an upward trend over time in the proportion of
ESBL among the analysed nosocomial infections due to Enter-
obacteriaceae (Fig. 1). The univariate analysis showed a statis-
tically signiﬁcant upward trend among surgical site infections (p
0.003), urinary tract infections (p <0.001) and lower respira-
tory tract infections (p <0.001) due to Escherichia coli (Table 1).
In the regression analysis, the following factors were asso-
ciated with a statistically signiﬁcant impact on the proportion of
ESBL between 2007 and 2012: surgical ICU (odds ratio (OR)
1.36), multidisciplinary ICU (OR 1.30) and hospital 400 beds
(1.20). The parameter of year was signiﬁcantly associated with
the ESBL-E proportion (OR 1.07), which represents a yearly
increase in the proportion of ESBL-E by 7%. Results are dis-
played in Table 2.
In the regression analysis for geographical distribution, the
following factors were associated with a signiﬁcantly increased
proportion of nosocomial infection due to ESBL-E: the federal
states of Thuringia (p 0.009; OR 1.53; 95% CI 1.11–2.09) and
North Rhine-Westphalia (p <0.001; OR 1.41; 95% conﬁdence
interval (CI) 1.17–1.69) and surgical ICU (p 0.002; OR 1.47,
95% CI 1.15–1.88). The geographical distribution from 2007 to
2012 in 2-year steps is shown in Fig. 2.obacteriaceae. *Statistically signiﬁcant trend (Cochrane-Armitage test).
respiratory tract infection; UTI, urinary tract infection; BSI, bloodstream
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TABLE 1. Participating departments and intensive care units per 2-year period, nosocomial infections and results of univariate
analysis for trend from 2007 to 2012 in ESBL proportion of nosocomial infections due to Enterobacteriaceae
Infection
2007–2008
ESBL
2009–2010
ESBL
2011–2012
EBSL p (Cochrane-Armitage test)Overall Overall Overall
Enterobacteriaceae infections 3951 469 (11.9%) 4542 681 (15.0%) 4409 680 (15.4%) <0.001*
Escherichia coli 2579 279 (10.8%) 2991 449 (15.0%) 2826 494 (17.5%) <0.001*
Klebsiella pneumoniae 1372 190 (13.8%) 1551 232 (15.0%) 1583 186 (11.7%) 0.091
OP-KISS
No. of surgical departments 432 558 681
Surgical site infection 593 64 (10.8%) 667 113 (16.9%) 681 118 (17.3%) 0.003*
E. coli 497 59 (11.9%) 557 103 (18.5) 550 107 (19.5%) 0.003*
K. pneumoniae 96 5 (5.2%) 110 10 (9.1%) 131 11 (8.4%) 0.584
ITS-KISS
No. of intensive care units 465 533 645
Lower respiratory tract infection 1768 221 (12.5%) 1945 303 (15.6%) 2241 330 (14.7%) 0.034*
E. coli 899 102 (11.3%) 1014 165 (16.3%) 1180 218 (18.5%) <0.001*
K. pneumoniae 869 119 (13.7%) 931 138 (14.8%) 1061 112 (10.6%) 0.040*
Urinary tract infection 1389 154 (11.1%) 1690 226 (13.4%) 1226 184 (15.0%) <0.001*
E. coli 1082 105 (9.7%) 1301 166 (12.8%) 969 142 (14.7%) <0.001*
K. pneumoniae 307 49 (16.0%) 389 60 (15.4%) 257 42 (16.3%) 0.845
Bloodstream infection 201 30 (14.9%) 240 39 (16.3%) 261 48 (18.4%) 0.350
E. coli 101 13 (12.9%) 119 15 (12.6%) 127 27 (21.3%) 0.064
K. pneumoniae 100 17 (17.0%) 121 24 (19.8%) 134 21 (15.7%) 0.635
ESBL, extended-spectrum β-lactamase; KISS, German national nosocomial infection surveillance system; OP, surgical department; ITS, intensive care unit. *Indicates statistical
signiﬁcance.
TABLE 2. Independent factors for alteration of ESBL
proportion of nosocomial infections due to Enterobacteria-
ceae between 2007 and 2012 frommultivariate analysis
Parameter OR 95% CI p
Year 1.073 1.042; 1.105 <0.0001
Age >70 years 0.806 0.690; 0.940 0.0062
Surgical ICU 1.357 1.146; 1.608 0.0004
Gynecology 0.371 0.150; 0.916 0.0316
Interdisciplinary ICU 1.296 1.153; 1.457 <0.0001
ICU other 0.832 0.698; 0.990 0.0385
Hospital 400 beds 1.201 1.078; 1.338 0.0009
Spring 0.877 0.781; 0.984 0.0257
ESBL, extended-spectrum β-lactamase; OR, odds ratio; CI, conﬁdence interval;
ICU, intensive care unit.
CMI Leistner et al. Distribution of nosocomial ESBL-E infections in Germany 255.e3DiscussionRising infection rates due to ESBL-E have been observed
internationally [7]. Our data conﬁrm these numbers for the
German hospitals participating in KISS and show a strong in-
crease of nosocomial ESBL-E infection in the midwest of Ger-
many. Interestingly, the lion’s share of the German pork
production is situated here (http://www.bmelv.de), and pork
has been linked to colonization with ESBL-E [8,9]. In Germany,
the majority of antibiotic consumption is found in agricultural
production [10]. However, building a causal relationship to-
wards rising rates of ESBL-positive organisms would over-
simplify the complexity of the existing facts [11,12]. There are
different ways of introduction and distribution of ESBL-positive
organisms that are being currently discussed, including the food
chain [11], selection pressure [10,13] and a concentrationClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Ingradient based in states with high colonization rates [8,14]. The
spread of ESBL-E is therefore likely to have a multifactorial
cause.
Studies on risk factors for acquisition of ESBL-positive or-
ganisms demonstrate that antibiotic treatment or hospital stay
[15,16] are important drivers. In Germany, 70% of single-shot
surgical prophylaxis is administered longer than recom-
mended [13]. The results at hand underline this assumption by
showing an association with surgical ICUs. Our results also
support the ﬁnding that infections due to gram-negative bac-
teria are less likely to occur in colder seasons [17]. Our data
conﬁrm several studies on infections due to ESBL-positive
bacteria that show a trend towards infections in patients
younger than 70 years old [18,19].
Our data did not derive from a random selection of German
hospitals but represent a considerable portion: 34% (n = 9011)
of the 26 162 existing ICU beds in 2012 are represented in our
network (http://www.gbe-bund.de). We did not adjust for po-
tential outbreak scenarios. The proportion found could there-
fore mirror casual outbreaks. However, the continuous trend
of ESBL-positive infections over time argues against this inter-
pretation. There is evidence that the larger part of hospital
infections due to Enterobacteriaceae is community acquired
[20]. Because our data is based on nosocomial infections, the
interpretation can only be valid for this type of infection.
Nosocomial infections are inﬂuenced by the hospital’s ecolog-
ical ﬂora and are suspected to be selected under the hospital’s
antimicrobial pressure.
The proportion of ESBL-positive nosocomial infections in
the last 6 years has signiﬁcantly increased in Germany.fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 255.e1–255.e5
FIG. 2. Comparison of federal state–dependent proportion of ESBL in nosocomial infections due to Enterobacteriaceae from ITS-KISS and OP-KISS
from 2007 to 2012. *Signiﬁcantly increased proportion in ESBL in 2011 and 2012 compared to other regions (multivariate logistic regression analysis).
ESBL, extended-spectrum β-lactamase; KISS, German national nosocomial infection surveillance system: ITS, intensive care unit; OP, postsurgery
patients.
255.e4 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIHospitals in central Germany and surgical ICUs are particularly
affected. It is important to implement and comply with effective
prevention measures to avoid further spread of these
organisms.Transparency declarationAll authors report no conﬂicts of interest relevant to this
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